Risk-Based Inspections Put Compliant Firms At Risk Of International Snags
This article was originally published in The Tan Sheet
Executive Summary
Industry exec asks FDA to help good manufacturers prove to other countries they continue to meet GMPs even if they are not inspected frequently.